Ohr Pharma's eye drug fails main goal in mid-stage study
March 27, 2015 at 07:31 AM EDT
March 27 (Reuters) - Ohr Pharmaceutical Inc said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy, sending the company's shares down 21 percent in premarket trading on Friday.